Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.57 |
| ▸ | CA9 | Q16790 | 4/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29871305 | 1.00 | CA12 (0.57) | CA12CA9CA1CA3CA4 | |
| Hydrochloric Acid SCHEMBL31179088 | 0.98 | CA12 (0.55) | CA12CA9CA1CA3CA4 | |
| SCHEMBL30804611 | 0.98 | CA12 (0.55) | CA12CA9CA1CA3CA4 | |
| Azetidine SCHEMBL29152261 | 0.91 | CA12 (0.53) | CA12CA9CA1CA3CA4 | |
| SCHEMBL10749595 | 0.88 | CA12 (0.53) | CA12CA9CA1CA3CA4 | |
| Pyridine SCHEMBL29180748 | 0.88 | CA12 (0.46) | CA12CA9CA1CA3CA4 | |
| SCHEMBL10614829 | 0.83 | PDE3B (0.46) | CA12CA9CA1CA3CA4 | |
| SCHEMBL2116388 | 0.83 | CA12 (0.53) | CA12CA9CA1CA3CA4 | |
| SCHEMBL9524505 | 0.80 | CA12 (0.56) | CA12CA9CA1CA3CA4 | |
| SCHEMBL4232096 | 0.78 | CA12 (0.41) | CA12CA9CA1CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12227613-B2 | Photo-patternable organic semiconductor (OSC) polymers and methods of formation and applications thereof | CORNING INCORPORATED (US) | 2025-02-18 | — | — | US | claimed |
| CN-118680931-A | Use of phenylquinolinone and flavonoid derivatives for treating neuropathic pain | 杭州百诚医药科技股份有限公司 | 2024-09-24 | — | — | CN | claimed |
| EP-4225812-B1 | KETOQUINOLONES AS PHOTONITIATORS | IGM RESINS ITALIA SRL (IT) | 2024-09-18 | — | — | EP | claimed |
| CN-117800963-A | Benzoquinolone-cilnidine compound containing exocyclic methylene and preparation method thereof | 合肥工业大学 | 2024-04-02 | — | — | CN | claimed |
| CN-117486875-A | Benzoquinolone-sibiricin alkaloid compound and application thereof | 山东大学 | 2024-02-02 | — | — | CN | claimed |
| US-20230331958-A1 | KETOQUINOLONES AS PHOTONITIATORS | IGM RESINS ITALIA S.R.L. (IT) | 2023-10-19 | — | — | US | claimed |
| EP-4225812-A1 | KETOQUINOLONES AS PHOTONITIATORS | IGM Resins Italia S.r.l. (IT) | 2023-08-16 | — | — | EP | claimed |
| CN-116438205-A | Ketoquinolones as photoinitiators | 意大利艾坚蒙树脂有限公司 | 2023-07-14 | — | — | CN | claimed |
| EP-3356369-B1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO (JP) | 2022-05-04 | — | — | EP | claimed |
| CN-114380982-A | Photopatternable Organic Semiconductor (OSC) polymers, methods of forming the same, and uses thereof | 康宁股份有限公司 | 2022-04-22 | — | — | CN | claimed |
| US-20220119591-A1 | PHOTO-PATTERNABLE ORGANIC SEMICONDUCTOR (OSC) POLYMERS AND METHODS OF FORMATION AND APPLICATIONS THEREOF | CORNING INCORPORATED | 2022-04-21 | — | — | US | claimed |
| CN-109111400-B | Preparation and application of phenylquinolinone and flavonoid derivatives | 杭州百诚医药科技股份有限公司 | 2020-10-16 | — | — | CN | claimed |
| US-20180269407-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO., LTD. (JP) | 2018-09-20 | — | — | US | claimed |
| WO-2005056826-A1 | TRANSCRIPTION-PATTERNED BIOLOGICAL ACTIVITY SCREENING SYSTEM | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2005-06-23 | — | — | WO | claimed |
| EP-0564193-A1 | Heteroannulation process | ELI LILLY AND COMPANY (US) | 1993-10-06 | — | — | EP | claimed |
| EP-0230967-B1 | BENZAZECINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1991-10-23 | — | — | EP | claimed |
| US-20260062412-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4647424-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-11-12 | — | — | EP | disclosed |
| US-4749791-A | Benzo[f]quinoline intermediates | HOFFMANN-LA ROCHE INC. (US) | 1988-06-07 | — | — | US | disclosed |
| US-4732979-A | CEREBRAL INSUFFICIENCY | HOFFMANN-LA ROCHE INC. (US) | 1988-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062412-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY | MYT1, NTMT1, MYL6 | CA12 1692/4885CA9 1476/4885CA1 1098/4885 |
| US-20180269407-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | ALDH1A2, TRPA1, CDK2 | CA12 4585/4885CA9 4301/4885CA1 3891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.